Literature DB >> 23794161

Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.

Richard E Stead1, Maryke A Fox, Emily Staples, Chea S Lim.   

Abstract

BACKGROUND: To present a case of melanoma-associated retinopathy (MAR) which manifested 26 months prior to a formal diagnosis of melanoma.
METHODS: Case report.
RESULTS: A 72-year-old female presented with bilateral continuous photopsia consistent with MAR of 7-months duration. At this point, visual function appeared normal with the exception of mildly impaired colour vision (10/17 Ishihara plates). The flash electroretinographic (ERG) revealed extinguished rod responses, a normal a-wave and reduced b-wave (electronegative ERG) on the maximal combined response, absent oscillatory potentials and broadened a-wave trough on the cone response. Multifocal ERG (mfERG) responses were delayed and demonstrated atypical morphology. Nineteen months after the initial presentation, her visual symptoms had progressed significantly with constant debilitating photopsia in combination with 13 kg weight loss. Biopsy of a now evident left axillary mass demonstrated a metastatic high-grade malignant melanoma. No primary was detected, and an axillary lymph node clearance was undertaken. Subsequently, visual symptoms resolved with corresponding improvement in the ERG over the next 18 months. Rod responses recovered such that the amplitude was at the lower limit of normal and the mfERG response delay lessened. Unfortunately, the melanoma recurred and the patient passed away 6 months later. Visual symptoms did not recur.
CONCLUSION: We present a case which demonstrates MAR may precede the formal diagnosis of melanoma by up to 26 months. The potential for improvement in the rod visual function persists over a period of years with normalisation of an electronegative waveform. In this case, cytoreductive surgery resulted in complete resolution of the MAR, which did not return even with a recurrence of the tumour.

Entities:  

Mesh:

Year:  2013        PMID: 23794161     DOI: 10.1007/s10633-013-9398-6

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  25 in total

1.  Standard for clinical electroretinography (2004 update).

Authors:  Michael F Marmor; Graham E Holder; Mathias W Seeliger; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

Review 2.  The negative ERG: clinical phenotypes and disease mechanisms of inner retinal dysfunction.

Authors:  Isabelle Audo; Anthony G Robson; Graham E Holder; Anthony T Moore
Journal:  Surv Ophthalmol       Date:  2008 Jan-Feb       Impact factor: 6.048

3.  Inner retinal layer loss in complicated migraine. Case report.

Authors:  L DuBois; A A Sadun; T B Lawton
Journal:  Arch Ophthalmol       Date:  1988-08

Review 4.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

5.  Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.

Authors:  Richard G Weleber; Robert C Watzke; William T Shults; Karmen M Trzupek; John R Heckenlively; Robert A Egan; Grazyna Adamus
Journal:  Am J Ophthalmol       Date:  2005-05       Impact factor: 5.258

Review 6.  Melanoma-associated retinopathy: does autoimmunity prolong survival?

Authors:  C Chan; J O'Day
Journal:  Clin Exp Ophthalmol       Date:  2001-08       Impact factor: 4.207

7.  Treatment of melanoma-associated retinopathy.

Authors:  Steven F Powell; Arkadiusz Z Dudek
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

8.  Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.

Authors:  Alexandr V Bazhin; Claudia Dalke; Nadine Willner; Oliver Abschütz; Hannes G H Wildberger; Pavel P Philippov; Reinhard Dummer; Jochen Graw; Martin Hrabé de Angelis; Dirk Schadendorf; Viktor Umansky; Stefan B Eichmüller
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

Review 9.  Autoimmune retinopathy: a review and summary.

Authors:  John R Heckenlively; Henry A Ferreyra
Journal:  Semin Immunopathol       Date:  2008-04-12       Impact factor: 9.623

10.  Spontaneous improvement of rod system function in a patient with melanoma-associated retinopathy.

Authors:  Linda S Kim; Kenneth R Alexander; Gerald A Fishman
Journal:  Retin Cases Brief Rep       Date:  2008
View more
  4 in total

1.  Case of paraneoplastic retinopathy with retinal ON-bipolar cell dysfunction and subsequent resolution of ERGs.

Authors:  Shinji Ueno; Ayami Nakanishi; Kayo Nishi; Shiro Suzuki; Hiroko Terasaki
Journal:  Doc Ophthalmol       Date:  2014-11-13       Impact factor: 2.379

2.  Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.

Authors:  Eleni Karatsai; Anthony G Robson; Simon R J Taylor
Journal:  JAMA Ophthalmol       Date:  2019-05-01       Impact factor: 7.389

Review 3.  An update on autoimmune retinopathy.

Authors:  Parthopratim Dutta Majumder; Alessandro Marchese; Francesco Pichi; Itika Garg; Aniruddha Agarwal
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

4.  Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody.

Authors:  Shinji Ueno; Yasuki Ito; Ruka Maruko; Mineo Kondo; Hiroko Terasaki
Journal:  Clin Ophthalmol       Date:  2014-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.